Cochrane Abstracts
Plasmapheresis to remove amyloid fibrin(ogen) particles for treating the post‐COVID‐19 condition
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Plasmapheresis to Remove Amyloid Fibrin(ogen) Particles for Treating the post‐COVID‐19 Condition." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/440511/all/Plasmapheresis_to_remove_amyloid_fibrin_ogen__particles_for_treating_the_post‐COVID‐19_condition.
Plasmapheresis to remove amyloid fibrin(ogen) particles for treating the post‐COVID‐19 condition. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/440511/all/Plasmapheresis_to_remove_amyloid_fibrin_ogen__particles_for_treating_the_post‐COVID‐19_condition. Accessed March 26, 2025.
Plasmapheresis to remove amyloid fibrin(ogen) particles for treating the post‐COVID‐19 condition. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/440511/all/Plasmapheresis_to_remove_amyloid_fibrin_ogen__particles_for_treating_the_post‐COVID‐19_condition
Plasmapheresis to Remove Amyloid Fibrin(ogen) Particles for Treating the post‐COVID‐19 Condition [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 March 26]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/440511/all/Plasmapheresis_to_remove_amyloid_fibrin_ogen__particles_for_treating_the_post‐COVID‐19_condition.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Plasmapheresis to remove amyloid fibrin(ogen) particles for treating the post‐COVID‐19 condition
ID - 440511
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/440511/all/Plasmapheresis_to_remove_amyloid_fibrin_ogen__particles_for_treating_the_post‐COVID‐19_condition
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
